Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Aldeyra Therapeutics Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

28 Feb 2015 Reuters Investment Profile 12 $20.00

ValuEngine Industry Report for Medical-drugs(ALDX)

Advanced academic research that brings you superior investment strategies in an actionable format. Industry Analysis Report, ...

05 Mar 2015 ValuEngine, Inc. 10 $49.00

ALDEXA THERAPEUTICS INC (ALDX) - REPORT FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

28 Feb 2015 Pechala's Reports 1 $25.00

ALDEXA THERAPEUTICS INC (ALDX) 12-months forecast

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

28 Feb 2015 Pechala's Reports 1 $15.00

ALDX: Novel aldehyde trapping approach could potentially afford new treatment modality in multiple diseases; initiation with a Buy rating and a 12-month price target of $30

We are initiating coverage of Aldeyra Therapeutics with a Buy rating and a $30 12-month price target. ALDX affords a novel al...

26 Jan 2015 Laidlaw & Company 31 $75.00

ALDX.OQ - Event Transcript of Aldeyra Therapeutics Inc conference call, Nov. 10, 2014 / 8:30AM ET

Edited Event Transcript of ALDX.OQ conference call, Nov. 10, 2014 / 8:30AM ET Boston, Nov 28, 2014 (Thomson StreetEvent...

10 Nov 2014 Thomson Reuters StreetEvents 9 $75.00

ALDX.OQ - Event Transcript of Aldeyra Therapeutics Inc conference call, Aug. 04, 2014 / 8:30AM ET

Edited Event Transcript of ALDX.OQ conference call, Aug. 04, 2014 / 8:30AM ET Boston, Nov 28, 2014 (Thomson StreetEvent...

04 Aug 2014 Thomson Reuters StreetEvents 9 $75.00